Menu
Not yet recruiting NCT06745427

A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

Observational Endometrial Cancer Endometrial Intraepithelial Neoplasia Fertility-sparing Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Endometrial Cancer, Endometrial Intraepithelial Neoplasia, Fertility-sparing Surgery. Basic parameters: 18 years — 45 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Detailed description

A multi-center prospective study on the oncological and reproductive outcomes and quality of life in young woman after fertility-sparing treatment of endometrial cancer and endometrial intraepithelial hyperplasia

Primary outcome measures

  • Relaps of endometrial cancer or EIN after fertility-sparing treatment [Time frame: from enrollment to 2 years after fertility-sparing treatment]
Secondary outcome measures (1)
  • Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN [Time frame: From start of study to 2 years after fertility-sparing treatment]

Eligibility criteria

Inclusion criteria

  • Fertility sparing treatment of EC and EIN.
  • 18-45 Years old
  • From start study (Jan 2025 - end study Jan 2028)
  • All centras in Sweden

Exclusion criteria

  • Not English och Swedish speaking

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06745427 · 2024048701

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗